Filed: 2/17/2026ACC: 0001953107-26-000003
📋 What this filing means
ENAVATE SCIENCES GP, LLC filed this quarterly 13F‑HR report disclosing 7 equity positions with a total reported market value of $506.78M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
7
Positions
$506.78M
Total AUM (reported)
27.08M
Total Shares
Allocation by class
COM$473.89M93.5%
COM NEW$32.89M6.5%
Portfolio Concentration
Top 3$346.68M68.4%
4–10$160.10M31.6%
Top 3 weight
68.4%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 27.08M
Sole
Full voting authority
27.08M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole7
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings7
Rows:
ZENAS BIOPHARMA INC
SOLEShares3.92M
TypeSH
Market value$142.30M
28.08%
Sole
3.92M
Shared
0.00
None
0.00
IMMUNOME INC
SOLEShares4.77M
TypeSH
Market value$102.43M
20.21%
Sole
4.77M
Shared
0.00
None
0.00
SIONNA THERAPEUTICS INC
SOLEShares2.48M
TypeSH
Market value$101.95M
20.12%
Sole
2.48M
Shared
0.00
None
0.00
UPSTREAM BIO INC
SOLEShares2.46M
TypeSH
Market value$66.78M
13.18%
Sole
2.46M
Shared
0.00
None
0.00
COMPASS THERAPEUTICS INC
SOLEShares7.79M
TypeSH
Market value$41.82M
8.25%
Sole
7.79M
Shared
0.00
None
0.00
BRIDGEBIO ONCOLOGY THERAPEUT
SOLEShares2.63M
TypeSH
Market value$32.89M
6.49%
Sole
2.63M
Shared
0.00
None
0.00
CAMP4 THERAPEUTICS CORP
SOLEShares3.04M
TypeSH
Market value$18.61M
3.67%
Sole
3.04M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
ZENAS BIOPHARMA INCSOLE | COM | 3.92M | SH | $142.30M 28.08% | 3.92M | 0.00 | 0.00 |
IMMUNOME INCSOLE | COM | 4.77M | SH | $102.43M 20.21% | 4.77M | 0.00 | 0.00 |
SIONNA THERAPEUTICS INCSOLE | COM | 2.48M | SH | $101.95M 20.12% | 2.48M | 0.00 | 0.00 |
UPSTREAM BIO INCSOLE | COM | 2.46M | SH | $66.78M 13.18% | 2.46M | 0.00 | 0.00 |
COMPASS THERAPEUTICS INCSOLE | COM | 7.79M | SH | $41.82M 8.25% | 7.79M | 0.00 | 0.00 |
BRIDGEBIO ONCOLOGY THERAPEUTSOLE | COM NEW | 2.63M | SH | $32.89M 6.49% | 2.63M | 0.00 | 0.00 |
CAMP4 THERAPEUTICS CORPSOLE | COM | 3.04M | SH | $18.61M 3.67% | 3.04M | 0.00 | 0.00 |